Clinical trial
Sirolimus for Autoimmune Disease of Blood Cells
NCT00392951 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00392951 |
|---|---|
| Title | Sirolimus for Autoimmune Disease of Blood Cells |
| Official title | Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Autoimmune Pancytopenia, Autoimmune Lymphoproliferative Syndrome (ALPS), Evans Syndrome, Idiopathic Thrombocytopenic Purpura, Anemia, Hemolytic, Autoimmune, Autoimmune Neutropenia, Lupus Erythematosus, Systemic and 2 more |
| Intervention type | Drug |
| Interventions | sirolimus |
| Enrollment | 30 |
| Start date | Dec 1, 2006 |
| Primary completion | Feb 1, 2016 |
| Completion | Feb 1, 2016 |
| First posted | Oct 26, 2006 |
| Last update posted | Nov 19, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: